H. Lee Moffitt Cancer Center & Research Institute

Find a Researcher

Amer A. Beg, PhD

Amer A. Beg, PhD

Faculty Rank:

Senior Member

Titles:

Department/Program Affiliations:

  • Immunology

Primary Address:

H. Lee Moffitt Cancer Center &
Research Institute
12902 Magnolia Drive
Tampa, FL 33612

Office:

(813) 745-5714

USF Affiliations/College Department:

  • Medicine / Oncologic Sciences

University Academic Rank:

Professor

For corrections, please e-mail a request

Printer friendly version
Printer friendly version (including publications)

Amer A. Beg, PhD

Education & Training:

  • M.S., Quaid-e-Azam University (Islamabad, Pakistan), 1987 - Biology
  • Ph.D., University of North Carolina- Chapel Hill, 1993 - Biology
  • Postdoctoral Fellowship, Rockefeller University, 1994
  • Postdoctoral Fellow, Massachusetts Institute of Technology, 1996

For corrections, please e-mail a request

Printer friendly version
Printer friendly version (including publications)

Amer A. Beg, PhD

Research Interests:

The NF-kappa B proteins comprise a family of transcription factors that regulate key genes involved in immune responses, inflammation, cell death and cell proliferation. A main focus of research in my laboratory is to understand the specific role played by different NF-kappa B subunits in regulating inflammatory and immune responses. These closely linked responses play a crucial role in protecting us from pathogens such as bacteria and viruses. However, impaired regulation of these responses also underlie many human ailments, including autoimmune disease and cancer. We are particularly interested in the role played by NF-kappa B proteins in dendritic cells (DCs) and T lymphocytes. Working together, these two cell types perhaps play the most important role in initiating an immune response. DCs capture bacterial and viral antigens, a process that also induces DC activation. These antigens are displayed on the surface of DCs, where they are recognized by the T cell receptor (TCR) present on T cells. In addition, various co-stimulatory molecules and cytokines expressed by activated DCs further help induce T cell proliferation and effector function. Through both direct and indirect mechanisms, T cells help eliminate infectious agents. In addition, there is great promise in harnessing the power of DCs in activating T cells capable of recognizing and destroying cancerous tissue.

Our studies utilize mice in which different subunits of NK-kappa B have been ?knocked-out?. Recent studies from my laboratory have shown that TCR engagement provides the primary NF-kappa B activating signal in T cells. Our in vitro and in vivo studies have further shown that NF-kappa B is essential for inducing cell cycle progression and survival of T cells. We are currently investigating the role played by different NF-kappa B subunits in generating effector and memory T cells, as well as their roles in modulating T cell responses in autoimmunity and cancer. In DCs, we have found essential roles for different NF-kappa B subunits in regulating DC development, survival and cytokine production. Current projects in the laboratory include investigation of mechanisms by which different NF-kappa B subunits specifically regulate genes involved in inflammation or immunity. For these studies, we are also utilizing techniques for genome wide analysis of gene expression in DCs. A better understanding of how different NF-kappa B subunits regulate unique aspects of DC function can open up new avenues for modulating DC function in infection, autoimmunity and cancer.

For corrections, please e-mail a request

Printer friendly version
Printer friendly version (including publications)

Amer A. Beg, PhD

Publications:

  1. Plumlee CR, Lee C, Beg AA, Decker T, Shuman HA, Schindler C. Interferons direct an effective innate response to Legionella pneumophila infection. J Biol Chem. 2009 Oct;284(44):30058-30066. Pubmedid: 19720834.   Pubmed ID: 19720834

  2. Valenzuela JO, Iclozan C, Hossain MS, Prlic M, Hopewell E, Bronk CC, Wang J, Celis E, Engelman RW, Blazar BR, Bevan MJ, Waller EK, Yu XZ, Beg AA. PKCtheta is required for alloreactivity and GVHD but not for immune responses toward leukemia and infection in mice. J Clin Invest. 2009 Nov;. Pubmedid: 19907075.   Pubmed ID: 19907075

  3. Wang J, Jacob NK, Ladner KJ, Beg A, Perko JD, Tanner SM, Liyanarachchi S, Fishel R, Guttridge DC. RelA/p65 functions to maintain cellular senescence by regulating genomic stability and DNA repair. EMBO Rep. 2009 Nov;10(11):1272-1278. Pubmedid: 19779484.   Pubmed ID: 19779484

  4. Ni H, Chen X, Shi Y, Liao Y, Beg A, Fan J, Yin X. Genetic delineation of the pathways mediated by Bid and JNK in TNFalpha-induced liver injury in adult and embryonic mice. J Biol Chem. 2008 Dec; (6). Pubmedid: 19060338.   Pubmed ID: 19060338

  5. Acharyya S, Villalta S, Bakkar N, Bupha-Intr T, Janssen P, Carathers M, Li Z, Beg A, Ghosh S, Sahenk Z, Weinstein M, Gardner K, Rafael-Fortney J, Karin M, Tidball J, Baldwin A, Guttridge D. Interplay of IKK/NF-kappaB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy. J Clin Invest. 2007 Apr;117(4):889-901. Pubmedid: 17380205.   Pubmed ID: 17380205

  6. Beg A, Sommer J, Martin J, Scheiffele P. alpha2-Chimaerin is an essential EphA4 effector in the assembly of neuronal locomotor circuits. Neuron. 2007 Sep;55(5):768-778. Pubmedid: 17785183.   Pubmed ID: 17785183

  7. Chen X, Ding W, Ni H, Gao W, Shi Y, Gambotto A, Fan J, Beg A, Yin X. Bid-independent Mitochondria Activation in TNF{alpha}-induced Apoptosis and Liver Injury. Mol Cell Biol. 2007 Jan;27(2):541-53. Pubmedid: 17101783.   Pubmed ID: 17101783

  8. Nefedova Y, Fishman M, Sherman S, Wang X, Beg A, Gabrilovich D. Mechanism of all-trans retinoic acid effect on tumor-associated myeloid-derived suppressor cells. Cancer Res. 2007 Nov;67(22):11021-11028. Pubmedid: 18006848.   Pubmed ID: 18006848

  9. Wang J, Wang X, Hussain S, Zheng Y, Sanjabi S, Ouaaz F, Beg A. Distinct Roles of Different NF-{kappa}B Subunits in Regulating Inflammatory and T Cell Stimulatory Gene Expression in Dendritic Cells. J Immunol. 2007 Jun;178(11):6777-6788. Pubmedid: 17513725.   Pubmed ID: 17513725

  10. Wang X, Hussain S, Wang E, Wang X, Li M, Garcia-Sastre A, Beg A. Lack of Essential Role of NF-{kappa}B p50, RelA, and cRel Subunits in Virus-Induced Type 1 IFN Expression. J Immunol. 2007 Jun;178(11):6770-6776. Pubmedid: 17513724.   Pubmed ID: 17513724

  11. Beg A, Scheiffele P. Neuroscience. SUMO wrestles the synapse. Science. 2006 Feb;311(5763):962-963. Pubmedid: 16484483.   Pubmed ID: 16484483

  12. Buttery P, Beg A, Chih B, Broder A, Mason C, Scheiffele P. The diacylglycerol-binding protein alpha1-chimaerin regulates dendritic morphology. Proc Natl Acad Sci U S A. 2006 Feb;103(6):1924-1929. Pubmedid: 16446429.   Pubmed ID: 16446429

  13. Nefedova Y, Cheng P, Gilkes D, Blaskovich M, Beg A, Sebti S, Gabrilovich DI. Activation of dendritic cells via inhibition of Jak2/STAT3 signaling. J Immunol. 2005 Oct;175(7):4338-4346. Pubmedid: 16177074.   Pubmed ID: 16177074

  14. Beg A. ComPPARtmentalizing NF-kappaB in the gut. Nat Immunol. 2004;5(1):14-16. Pubmedid: 14699401.   Pubmed ID: 14699401

  15. Saccani S, Marazzi I, Beg A, Natoli G. Degradation of promoter-bound p65/RelA is essential for the prompt termination of the nuclear factor kappaB response. J Exp Med. 2004;200(1):107-113. Pubmedid: 15226358.   Pubmed ID: 15226358

  16. Schuske K, Beg A, Jorgensen E. The GABA nervous system in C. elegans. Trends Neurosci. 2004 Jul;27(7):407-414. Pubmedid: 15219740.   Pubmed ID: 15219740

  17. Beg A, Jorgensen E. EXP-1 is an excitatory GABA-gated cation channel. Nat Neurosci. 2003 Nov;6(11):1145-1152. Pubmedid: 14555952.   Pubmed ID: 14555952

  18. Prendes M, Zheng Y, Beg A. Regulation of developing B cell survival by RelA-containing NF-kappa B complexes. J Immunol. 2003;171(8):3963-3969. Pubmedid: 14530314.   Pubmed ID: 14530314

  19. Qu J, Li X, Novitch B, Zheng Y, Kohn M, Xie J, Kozinn S, Bronson R, BegAA, Minden A. PAK4 kinase is essential for embryonic viability and for proper neuronal development. Mol Cell Biol. 2003;23(20):7122-7133. Pubmedid: 14517283.   Pubmed ID: 14517283

  20. Zheng Y, Vig M, Lyons J, Van Parijs L, Beg A. Combined deficiency of p50 and cRel in CD4+ T cells reveals an essential requirement for nuclear factor kappaB in regulating mature T cell survival and in vivo function. J Exp Med. 2003;197(7):861-874. Pubmedid: 12668645.   Pubmed ID: 12668645

  21. Beg A. Endogenous ligands of Toll-like receptors: implications for regulating inflammatory and immune responses. Trends Immunol. 2002;23(11):509-512. Pubmedid: 12401394.   Pubmed ID: 12401394

  22. Ouaaz F, Arron J, Zheng Y, Choi Y, Beg A. Dendritic cell development and survival require distinct NF-kappaB subunits. Immunity. 2002;16(2):257-270. Pubmedid: 11869686.   Pubmed ID: 11869686

  23. Tao X, Xu Y, Zheng Y, Beg A, Tong L. An extensively associated dimer in the structure of the C713S mutant of the TIR domain of human TLR2. Biochem Biophys Res Commun. 2002;299(2):216-221. Pubmedid: 12437972.   Pubmed ID: 12437972

  24. Alcamo E, Mizgerd J, Horwitz B, Bronson R, Beg A, Scott M, Doerschuk C, Hynes R, Baltimore D. Targeted mutation of TNF receptor I rescues the RelA-deficient mouse and reveals a critical role for NF-kappa B in leukocyte recruitment. J Immunol. 2001 Aug;167(3):1592-1600. Pubmedid: 11466381.   Pubmed ID: 11466381

  25. Li M, Carpio D, Zheng Y, Bruzzo P, Singh V, Ouaaz F, Medzhitov R, Beg A. An essential role of the NF-kappa B/Toll-like receptor pathway in induction of inflammatory and tissue-repair gene expression by necrotic cells. J Immunol. 2001 Jun;166(12):7128-7135. Pubmedid: 11390458.   Pubmed ID: 11390458

  26. Li M, Shillinglaw W, Henzel W, Beg A. The Rela(p65) subunit of NF-kappaB is essential for inhibiting double-stranded RNA-induced cytotoxicity. J Biol Chem. 2001 Jan;276(2):1185-1194. Pubmedid: 11035014.   Pubmed ID: 11035014

  27. Zheng Y, Ouaaz F, Bruzzo P, Singh V, Gerondakis S, Beg A. NF-kappa B RelA (p65) is essential for TNF-alpha-induced fas expression but dispensable for both TCR-induced expression and activation-induced cell death. J Immunol. 2001 Apr;166(8):4949-4957. Pubmedid: 11290773.   Pubmed ID: 11290773

  28. Bitzer M, von Gersdorff G, Liang D, Dominguez-Rosales A, Beg A, Rojkind M, Bottinger E. A mechanism of suppression of TGF-beta/SMAD signaling by NF-kappa B/RelA. Genes Dev. 2000 Jan;14(2):187-197. Pubmedid: 10652273.   Pubmed ID: 10652273

  29. Li M, Beg A. Induction of necrotic-like cell death by tumor necrosis factor alpha and caspase inhibitors: novel mechanism for killing virus-infected cells. J Virol. 2000 Aug;74(16):7470-7477. Pubmedid: 10906200.   Pubmed ID: 10906200

  30. Wang X, Li M, Zheng H, Muster T, Palese P, Beg A, Garcia-Sastre A. Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon. J Virol. 2000 Dec;74(24):11566-11573. Pubmedid: 11090154.   Pubmed ID: 11090154

  31. Bamber B, Beg A, Twyman R, Jorgensen E. The Caenorhabditis elegans unc-49 locus encodes multiple subunits of a heteromultimeric GABA receptor. J Neurosci. 1999 Jul;19(13):5348-5359. Pubmedid: 10377345.   Pubmed ID: 10377345

  32. Ouaaz F, Li M, Beg A. A critical role for the RelA subunit of nuclear factor kappaB in regulation of multiple immune-response genes and in Fas-induced cell death. J Exp Med. 1999 Mar;189(6):999-1004. Pubmedid: 10075983.   Pubmed ID: 10075983

  33. Finco T, Westwick J, Norris J, Beg A, Der C, Baldwin AS J. Oncogenic Ha-Ras-induced signaling activates NF-kappaB transcriptional activity, which is required for cellular transformation. J Biol Chem. 1997 Sep;272(39):24113-24116. Pubmedid: 09305854.   Pubmed ID: 09305854

  34. Beg A, Baltimore D. An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science. 1996 Nov;274(5288):782-784. Pubmedid: 08864118.   Pubmed ID: 08864118

  35. Baltimore D, Beg A. DNA-binding proteins. A butterfly flutters by. Nature. 1995 Jan;373(6512):287-288. Pubmedid: 07830761.   Pubmed ID: 07830761

  36. Beg A, Sha W, Bronson R, Baltimore D. Constitutive NF-kappa B activation, enhanced granulopoiesis, and neonatal lethality in I kappa B alpha-deficient mice. Genes Dev. 1995 Nov;9(22):2736-2746. Pubmedid: 07590249.   Pubmed ID: 07590249

  37. Beg A, Sha W, Bronson R, Ghosh S, Baltimore D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature. 1995 Jul;376(6536):167-170. Pubmedid: 07603567.   Pubmed ID: 07603567

  38. Beg A, Baldwin AS J. Activation of multiple NF-kappa B/Rel DNA-binding complexes by tumor necrosis factor. Oncogene. 1994 May;9(5):1487-1492. Pubmedid: 08152812.   Pubmed ID: 08152812

  39. Finco T, Beg A, Baldwin AS J. Inducible phosphorylation of I kappa B alpha is not sufficient for its dissociation from NF-kappa B and is inhibited by protease inhibitors. Proc Natl Acad Sci U S A. 1994 Dec;91(25):11884-11888. Pubmedid: 07991551.   Pubmed ID: 07991551

  40. Beg A, Baldwin AS J. The I kappa B proteins: multifunctional regulators of Rel/NF-kappa B transcription factors. Genes Dev. 1993 Nov;7(11):2064-2070. Pubmedid: 08224838.   Pubmed ID: 08224838

  41. Beg A, Finco T, Nantermet P, Baldwin AS J. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I kappa B alpha: a mechanism for NF-kappa B activation. Mol Cell Biol. 1993 Jun;13(6):3301-3310. Pubmedid: 08497253.   Pubmed ID: 08497253

  42. Scheinman R, Beg A, Baldwin AS J. NF-kappa B p100 (Lyt-10) is a component of H2TF1 and can function as an I kappa B-like molecule. Mol Cell Biol. 1993 Oct;13(10):6089-6101. Pubmedid: 08413211.   Pubmed ID: 08413211

  43. Beg A, Ruben S, Scheinman R, Haskill S, Rosen C, Baldwin AS J. I kappa B interacts with the nuclear localization sequences of the subunits of NF-kappa B: a mechanism for cytoplasmic retention. Genes Dev. 1992 Oct;6(12):2664-2665. Pubmedid: 01340770.   Pubmed ID: 01340770

  44. Baldwin AS J, Azizkhan J, Jensen D, Beg A, Coodly L. Induction of NF-kappa B DNA-binding activity during the G0-to-G1 transition in mouse fibroblasts. Mol Cell Biol. 1991 Oct;11(10):4943-4951. Pubmedid: 01922027.   Pubmed ID: 01922027

  45. Haskill S, Beg A, Tompkins S, Morris J, Yurochko A, Sampson-Johannes A, Mondal K, Ralph P, Baldwin AS J. Characterization of an immediate-early gene induced in adherent monocytes that encodes I kappa B-like activity. Cell. 1991 Jun;65(7):1281-1289. Pubmedid: 01829648.   Pubmed ID: 01829648

  46. Beg A, Varma V, Dash R. Effect of chlorpromazine on human growth hormone. Am J Psychiatry. 1979 Jul;136(7):914-917. Pubmedid: 0453353 .   Pubmed ID: 0453353

Amer A. Beg, PhD

Below is a list of active grants where the faculty member is the Principal Investigator. Grants are sorted by sponsor and then sorted by start date, with the more recent grant shown first.

Mechanisms of Co-simulatory Molecule Expression in DC's

5 R01 AI159715-05
Sponsor: Nat Institutes of Health / NIAID
Project Dates: March 1, 2006 to February 28, 2010
Annual Direct Cost: $209,288
Annual Total Cost: $341,139
Project Total: $1,780,274

Myeloid Derived Suppressor Cells in Tobacco-related Cancers

09KT-01
Sponsor: State of Florida / Dept of Health
Project Dates: July 1, 2009 to June 30, 2010
Earned to Date: $125,000

Researcher  Contact Form


© Copyright 1996 - 2009 H. Lee Moffitt Cancer Center & Research Institute